Plasma high density lipoprotein (HDL) levels are strongly genetically determined and show a general inverse relationship with coronary heart disease (CHD). The cholesteryl ester transfer protein (CETP) mediates the transfer of cholesteryl esters from HDL to other lipoproteins and is a key participant in the reverse transport of cholesterol from the periphery to the liver. A high prevalence of two different CETP gene mutations (D442G, 5.1%; intron 14G:A, 0.5%), was found in 3,469 men of Japanese ancestry in the Honolulu Heart Program and mutations were associated with decreased CETP (-35%) and increased HDL chol levels (+10% for D442G). However, the overall prevalence of definite CHD was 21% in men with mutations and 16% in men without mutations. The relative risk (RR) of CHD was 1.43 in men with mutations (P < .05); after adjustment for CHD risk factors, the RR was 1.55 (P = .02); after additional adjustment for HDL levels, the RR was 1.68 (P = .008). Similar RR values were obtained for the D442G mutation alone. Increased CHD in men with mutations was primarily observed for HDL chol 41-60 mg/dl; for HDL chol > 60 mg/dl men with and without mutations had low CHD prevalence. Thus, genetic CETP deficiency appears to be an independent risk factor for CHD, primarily due to increased CHD prevalence in men with the D442G mutation and HDL cholesterol between 41 and 60 mg/dl. The findings suggest that both HDL concentration and the dynamics of cholesterol transport through HDL (i.e., reverse cholesterol transport) determine the anti-atherogenicity of the HDL fraction.
S Zhong, D S Sharp, J S Grove, C Bruce, K Yano, J D Curb, A R Tall
Title and authors | Publication | Year |
---|---|---|
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd |
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology | 2009 |
Genetic-epidemiological evidence on genes associated with HDL cholesterol levels: A systematic in-depth review
E Boes, S Coassin, B Kollerits, IM Heid, F Kronenberg |
Experimental Gerontology | 2009 |
Association between change in high density lipoprotein cholesterol and cardiovascular disease morbidity and mortality: systematic review and meta-regression analysis
M Briel, I Ferreira-Gonzalez, JJ You, PJ Karanicolas, EA Akl, P Wu, B Blechacz, D Bassler, X Wei, A Sharman, I Whitt, SA da Silva, Z Khalid, AJ Nordmann, Q Zhou, SD Walter, N Vale, N Bhatnagar, C O'Regan, EJ Mills, HC Bucher, VM Montori, GH Guyatt |
BMJ (Clinical research ed.) | 2009 |
Effects of nevirapine and efavirenz on HDL cholesterol levels and reverse cholesterol transport in mice
J Tohyama, JT Billheimer, IV Fuki, GH Rothblat, DJ Rader, JS Millar |
Atherosclerosis | 2009 |
The hypertension peril: Lessons from CETP inhibitors
M Hermann, FT Ruschitzka |
Current Hypertension Reports | 2009 |
The role of plasma lipid transfer proteins in lipoprotein metabolism and atherogenesis
D Masson, XC Jiang, L Lagrost, AR Tall |
Journal of lipid research | 2009 |
Association of circulating cholesteryl ester transfer protein activity with incidence of cardiovascular disease in the community
RS Vasan, MJ Pencina, SJ Robins, JP Zachariah, G Kaur, RB D'Agostino, JM Ordovas |
Circulation | 2009 |
Altered composition of triglyceride-rich lipoproteins and coronary artery disease in a large case–control study
PN Hopkins, MN Nanjee, LL Wu, MG McGinty, EA Brinton, SC Hunt, JL Anderson |
Atherosclerosis | 2009 |
Association of ApoE and HDL-C with cardiovascular and cerebrovascular disease: potential benefits of LDL-apheresis therapy
PM Moriarty |
Clinical Lipidology | 2009 |
Latest Insights Into High-Density Lipoprotein Functions
H Noto |
The Endocrinologist | 2009 |
Association of Two CETP Polymorphisms With HDL Levels in the Chinese Obese Population
X Ruan, L Ma, S Wang, K Lindpaintner, X Liu, B Wang, Z Peng, X Ma, M Cheng, J Zhang, L Liu, X Wang |
Obesity | 2009 |
CETP antagonism versus agonism in cardiovascular prevention and plaque regression
CR Sirtori, G Mombelli |
Clinical Lipidology | 2009 |
Discovery and Validation of New Molecular Targets in Treating Dyslipidemia: The Role of Human Genetics
AV Khera, DJ Rader |
Trends in Cardiovascular Medicine | 2009 |
Frequency and function of CETP variants among individuals of Asian ancestry
JF Thompson, JM Reynolds, SP Williams, LS Wood, SA Paciga, DB Lloyd |
Atherosclerosis | 2009 |
The end of the road for CETP inhibitors after torcetrapib?
T Joy, RA Hegele |
Current Opinion in Cardiology | 2009 |
Cholesterol Ester Transfer Protein Inhibition: Understanding the Problems
IJ Goldberg |
Journal of Cardiovascular Pharmacology | 2009 |
Association of cholesteryl ester transfer protein −629C > A polymorphism with high-density lipoprotein cholesterol levels in coronary artery disease patients
S Tanrikulu, E Ademoglu, F Gurdol, U Mutlu-Turkoglu, AK Bilge, Y Nisanci |
Cell Biochemistry and Function | 2009 |
Human CETP aggravates atherosclerosis by increasing VLDL-cholesterol rather than by decreasing HDL-cholesterol in APOE*3-Leiden mice
JV der Weij, S Zadelaar, K Toet, LM Havekes, T Kooistra, PC Rensen |
Atherosclerosis | 2009 |
Promoting Mechanisms of Vascular Health
PR Moreno, J Sanz, V Fuster |
Journal of the American College of Cardiology | 2009 |
TaqIBpolymorphism in cholesterol ester transfer protein (CETP) gene predicts future cardiovascular death in patients experiencing an acute coronary syndrome
X Pillois, NP Thi, A Reynaud, D Benchimol, L Lagrost, J Bonnet |
Clinical Chemistry and Laboratory Medicine | 2009 |
Ciprofibrate increases cholesteryl ester transfer protein gene expression and the indirect reverse cholesterol transport to the liver
EJ Bighetti, PR Patrício, AC Casquero, JA Berti, HC Oliveira |
Lipids in Health and Disease | 2009 |
Lipoproteins, cholesterol homeostasis and cardiac health
TF Daniels, KM Killinger, JJ Michal, RW Wright, Z Jiang |
International journal of biological sciences | 2009 |
Elevated high-density lipoprotein (HDL) levels due to hepatic lipase mutations do not reduce cardiovascular disease risk: another strike against the HDL dogma
S Fazio, MR Linton |
The Journal of clinical endocrinology and metabolism | 2009 |
Cholesteryl ester transfer protein TaqIB, −629C>A and I405V polymorphisms and risk of coronary heart disease in an Indian population
N Padmaja, RM Kumar, J Balachander, C Adithan |
Clinica Chimica Acta | 2009 |
Cholesterylestertransfer protein inhibition and endothelial function in type II hyperlipidemia
F Hermann, F Enseleit, LE Spieker, D Périat, I Sudano, M Hermann, R Corti, G Noll, F Ruschitzka, TF Lüscher |
Thrombosis Research | 2009 |
Safety and Tolerability of Dalcetrapib
EA Stein, ES Stroes, G Steiner, BM Buckley, AM Capponi, T Burgess, EJ Niesor, D Kallend, JJ Kastelein |
The American Journal of Cardiology | 2009 |
Genomics and Cardiovascular Drug Development
AS Plump, PY Lum |
Journal of the American College of Cardiology | 2009 |
The Genetics of High-Density Lipoprotein Metabolism: Clinical Relevance for Therapeutic Approaches
AC Strang, GK Hovingh, ES Stroes, JJ Kastelein |
The American Journal of Cardiology | 2009 |
The Pharmacology and Off-Target Effects of Some Cholesterol Ester Transfer Protein Inhibitors
M Vergeer, ES Stroes |
The American Journal of Cardiology | 2009 |
A Translational Medicine perspective of the development of torcetrapib: Does the failure of torcetrapib development cast a shadow on future development of lipid modifying agents, HDL elevation strategies or CETP as a viable molecular target for atherosclerosis? A case study of the use of biomarkers and Translational Medicine in atherosclerosis drug discovery and development
L Zhao, W Jin, D Rader, C Packard, G Feuerstein |
Biochemical Pharmacology | 2009 |
Inflammation and Infection Do Not Promote Arterial Aging and Cardiovascular Disease Risk Factors among Lean Horticulturalists
M Gurven, H Kaplan, J Winking, DE Rodriguez, S Vasunilashorn, JK Kim, C Finch, E Crimmins, H Harpending |
PloS one | 2009 |
Polymorphism in the CETP Gene Region, HDL Cholesterol, and Risk of Future Myocardial Infarction: Genomewide Analysis Among 18 245 Initially Healthy Women From the Women’s Genome Health Study
PM Ridker, G Paré, AN Parker, RY Zee, JP Miletich, DI Chasman |
Circulation. Cardiovascular genetics | 2009 |
A deficiency of cholesteryl ester transfer protein whose serum remnant-like particle-triglyceride significantly increased, but serum remnant-like particle-cholesterol did not after an oral fat load
M Ai, A Tanaka, K Shimokado, R Ohtani, A Inazu, J Kobayashi, H Mabuchi, T Nakano, K Nakajima |
Annals of Clinical Biochemistry | 2009 |
Hepatic Lipase, Genetically Elevated High-Density Lipoprotein, and Risk of Ischemic Cardiovascular Disease
TH Johannsen, PR Kamstrup, RV Andersen, GB Jensen, H Sillesen, A Tybjærg-Hansen, BG Nordestgaard |
The Journal of clinical endocrinology and metabolism | 2009 |